Yi Xia

State Key Laboratory Of Advanced Medical Materials And Devices, Tianjin Key Laboratory Of Radiation Medicine And Molecular Nuclear Medicine, Key Laboratory Of Radiopharmacokinetics For Innovative Drugs, Chinese Academy Of Medical Sciences & Peking Union Medical College, Tianjin 300192, PR China
Union, Puerto Rico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Design and advances in antioxidant hydrogels for ROS-induced oxidative disease.

Design and advances in antioxidant hydrogels for ROS-induced oxidative disease.

Journal: Acta biomaterialia
Published: September 30, 2024

Modulating the complement system through epitope-specific inhibition by complement C3 inhibitors.

Modulating the complement system through epitope-specific inhibition by complement C3 inhibitors.

Journal: The Journal of biological chemistry
Published: July 16, 2024

Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial.

Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Published: October 16, 2023

Brain activity differences between difficulty in falling asleep and early awakening symptoms in major depressive disorder: A resting-state fMRI study.

Brain activity differences between difficulty in falling asleep and early awakening symptoms in major depressive disorder: A resting-state fMRI study.

Journal: Psychiatry research. Neuroimaging
Published: June 08, 2023

Response to the Letter to the editor regarding "Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma" by Jiong Lin.

Response to the Letter to the editor regarding "Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma" by Jiong Lin.

Journal: Cancer letters
Published: November 27, 2020

Interactions with ctDNA of novel sugar-based gemini cationic surfactants.

Interactions with ctDNA of novel sugar-based gemini cationic surfactants.

Journal: International journal of biological macromolecules
Published: January 22, 2020

Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma.

Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma.

Journal: Cancer letters
Published: January 04, 2020

The pretreatment albumin to globulin ratio predicts survival in patients with natural killer/T-cell lymphoma.

The pretreatment albumin to globulin ratio predicts survival in patients with natural killer/T-cell lymphoma.

Journal: PeerJ
Published: November 17, 2015

Therapeutic potential of tyrosine kinase 2 in autoimmunity.

Therapeutic potential of tyrosine kinase 2 in autoimmunity.

Journal: Expert opinion on therapeutic targets
Published: March 25, 2014

Role of the Akt/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity.

Role of the Akt/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity.

Journal: Brain research
Published: March 21, 2014

An efficient mixed-ligand Pd catalytic system to promote C-N coupling for the synthesis of N-arylaminotriazole nucleosides.

An efficient mixed-ligand Pd catalytic system to promote C-N coupling for the synthesis of N-arylaminotriazole nucleosides.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: December 14, 2011
Showing 1-11 of 11

Last Updated: 09/26/2026